LAURIE QUATTRO: Open Payments
NPI 1659764108 · CHANDLER, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,455 in 77 payments from 18 companies in 2025. Trend: 2023 $1,943 · 2024 $1,761 · 2025 $1,455
Food & beverage: $1,455
| Company | Payments | Amount |
|---|---|---|
| LEO Pharma Inc. | 20 | $408 |
| ABBVIE INC. | 18 | $247 |
| Novartis Pharmaceuticals Corporation | 9 | $213 |
| PFIZER INC. | 5 | $95 |
| GENZYME CORPORATION | 4 | $92 |
| Regeneron Healthcare Solutions, Inc. | 3 | $71 |
| Incyte Corporation | 3 | $59 |
| Arcutis Biotherapeutics, Inc. | 2 | $45 |
| Lilly USA, LLC | 2 | $40 |
| UCB, Inc. | 2 | $35 |
Products named: ADBRY, SKYRIZI, COSENTYX, ANZUPGO, DUPIXENT, Rhapsido, CIBINQO, OPZELURA.
Industry payments across AZ — which companies pay providers there.
